News
UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
1d
GlobalData on MSNBavarian Nordic launches chikungunya vaccine trial for paediatric populationBavarian Nordic has commenced a Phase III trial of its chikungunya vaccine, CHIKV VLP, targeting the paediatric population ...
France confirms its first locally transmitted chikungunya case of 2025 in La Crau, Var, as health officials ramp up mosquito control efforts.
Paris: Health authorities in France have confirmed the first locally transmitted case of mosquito-borne chikungunya this year ...
Women appear more susceptible to chikungunya, with 58.6% of reported cases affecting females, compared to 42.6% among males, ...
Health authorities in France have confirmed the first locally transmitted case of mosquito-borne chikungunya this year.The R ...
First children vaccinated in clinical study seeking to expand the target population for the chikungunya vaccine. COPENHAGEN, ...
2d
News-Medical.Net on MSNChikungunya vaccine could stop millions of infections worldwide, study findsA landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...
Results from the Phase II VLA1553-221 trial show that a full dose of Ixchiq demonstrated a 96.5% seroresponse rate in ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results